Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury

CONTEXT: Recombinant factor VIIa (rFVIIa) has been used as an adjunctive therapy for acute post-traumatic hemorrhage and reversal of iatrogenic coagulopathy in trauma patients in the hospital setting. However, investigations regarding its potential use in pre-hospital management of traumatic brain i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Bobby, Haque, Ashraful, Arnaud, Françoise G., Teranishi, Kohsuke, Steinbach, Thomas, Auker, Charles R., McCarron, Richard M., Freilich, Daniel, Scultetus, Anke H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013725/
https://www.ncbi.nlm.nih.gov/pubmed/24812455
http://dx.doi.org/10.4103/0974-2700.130880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013725/
https://www.ncbi.nlm.nih.gov/pubmed/24812455
http://dx.doi.org/10.4103/0974-2700.130880

Ejemplares similares